Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

MedPal AI

Artificial_Intelligence

AI in Healthcare and Digital Health Today—April 20, 2026

This week’s Artificial Intelligence and Digital Health update highlights…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Today—January 12, 2026

This AI in Healthcare and Digital Health roundup highlights accelerating…

by Timos Papagatsias

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Pfizer Innovent Oncology Deal | Lucid Diligence Brief
Respiratory Today—May 29, 2026
Vaccines Today—May 29, 2026
Public Health Today—May 29, 2026
Secretome STM-01 Duchenne Cardiomyopathy | Lucid Diligence Brief

Tags

Allergic fungal rhinosinusitis antibodies antiviral B-cell acute lymphoblastic leukemia Cardiac arrhythmias clinical innovation CRO data platforms Diazoxide Choline Evenity FibroBiologics fibrosis galactosemia Google Quantum AI Hesperos HIV self-testing IDH-mutant glioma Indolent B-cell non Hodgkin lymphoma inflammatory skin diseases interoperability intracellular targets Kallyope Lean Mass leukogene therapeutics Liso cel Metabolic dysfunction associated steatohepatitis mitral regurgitation Neurodegenerative disorders Nobel Prize Oragenics oral SERD protein design Public Health Emergency of International Concern Rett syndrome roflumilast Smart Implant Swissmedic Sword Health Syneos Health TEV-749 Transcatheter Aortic Valve Replacement vilobelimab Wave Life Sciences WOMEN Obstetrics & Gynecology Yuhan Corporation

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Pfizer Innovent Oncology Deal | Lucid Diligence Brief
Respiratory Today—May 29, 2026
Vaccines Today—May 29, 2026
Public Health Today—May 29, 2026
Secretome STM-01 Duchenne Cardiomyopathy | Lucid Diligence Brief

TAGS

Allergic fungal rhinosinusitis antibodies antiviral B-cell acute lymphoblastic leukemia Cardiac arrhythmias clinical innovation CRO data platforms Diazoxide Choline Evenity FibroBiologics fibrosis galactosemia Google Quantum AI Hesperos HIV self-testing IDH-mutant glioma Indolent B-cell non Hodgkin lymphoma inflammatory skin diseases interoperability intracellular targets Kallyope Lean Mass leukogene therapeutics Liso cel Metabolic dysfunction associated steatohepatitis mitral regurgitation Neurodegenerative disorders Nobel Prize Oragenics oral SERD protein design Public Health Emergency of International Concern Rett syndrome roflumilast Smart Implant Swissmedic Sword Health Syneos Health TEV-749 Transcatheter Aortic Valve Replacement vilobelimab Wave Life Sciences WOMEN Obstetrics & Gynecology Yuhan Corporation

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy